ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Biogen and Invitae to Offer Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients
August 21, 2019Biogen Inc. and Invitae Corporation have announced that SMA STAT, a new, rapid-turnaround genetic test for spinal muscular atrophy (SMA), will be offered at no charge to individuals in the U.S. as part of the SMA Identified program. -
Sarepta taps Invitae to identify participants for DMD trials
May 08, 2018Sarepta Therapeutics has partnered with genetic testing company Invitae to identify participants for its Duchenne muscular dystrophy (DMD) clinical trials. The initiative taps into the networks Invitae ...
Pharma Sources Insight January 2025
